Clinical observation of qianlie shutong capsule combined with α1A receptor blocker in treatment of damp heat and blood stasis type III prostatitis

Objectives To prospective study the clinical effect of the treatment of type Ⅲll prostatitis with QianlieShutong Capsule Combined with α1 A receptor blocker.Methods 120 patients with damp heat and blood stasis type Ⅲ prostatitis were randomly divided into observation group and control group,were treated with Qianlie Shutong Capsule (3capsules,3 times daily) plus tamsulosin hydrochloride capsules (0.2mg,1 night) and tamsulosin hydrochloride capsules (0.2 mg,every night 1) after 8 weeks treatment,according to American National Institutes of Health (NIH) formulation of the prostate symptom score (CPSI),international index of erectile function (IIEF-5) symptom quantization of two groups of patients,and observe the changes of lecithin in prostatic fluid,WBC,pH value of the body before and after the treatment,clinical efficacy compared two groups of patients and their side effects.Results After 8 weeks of treatment,the observation group and the control group,NIH-CPSI score,QOL score and the number of white cells in the EPS decreased significantly(P ＜0.01),but the observation group decreased significantly compared with control group (P ＜ 0.01).Conclusions QianlieShutong Capsule Combined with α1A receptor blocker in treatment of damp heat and blood stasis type Ⅲ prostatitis than single use ofα1A receptor blocker has obvious curative effect,is worth the clinical promotion.The clinical effects of theα1 A receptor blocker and Qianlieshu capsule treatment of type Ⅲ prostatitis Key words: Prostatitis Capsules;  Adrenergic alpha-Antagonists